---

Annalisa Jenkins

Chief Executive Officer, PlaqueTec

Annalisa began her first tour of duty with the Royal Navy as a medical officer, but has since climbed the ranks of pharma to become a CEO and a member of numerous boards, including PlaqueTec – a UK diagnostics company developing a novel approach to assess an individual’s risk for coronary artery disease. “I’m driven by a passion for making peoples’ lives longer, healthier and happier, ensuring that great science is translated effectively into new options for patients globally, and inspiring the next generation to make a difference. In the future, I’d like to see diversity at the top recognized as a business and human right imperative, and girls in school embracing STEM. I’m also passionate about innovative and progressive business models that seek to ensure that the discoveries and products of our industry benefit every human being on the planet.”

---

Part of the Power List 2018

The World’s Top 100 Medicine Makers

Bringing new drugs to patients is an incredibly difficult task that involves numerous indispensable actors – from pioneering entrepreneurs and CEOs, to industry experts, to dedicated researchers, to regulators who keep everyone on the right tracks.

Go to The Power List 2018